Ken Griffin and Citadel put a Damper on E-Trade’s Best Close of the Year

Michael Teague |

Ken Griffin and Citadel put a Damper on E-Trade’s Best Close of the YearKen Griffin, billionaire hedge fund manager and founder of Citadel LLC, just put the brakes on E-Trade Financial Corp.'s (ETFC) 52-week high ($11.82 per share close Wednesday) with the announcement that he would be selling the entirety of his 9.6 percent stake in the company, or about 27.4 million shares.

The news sent shares of E-Trade plummeting over 7 percent on Thursday to $10.99.

The relationship between E-Trade and Griffin began back in late 2007, when Citadel pumped $2.6 billion into the company. Much of this was to cover a batch of bad mortgages and loans that the company had taken on prior to the tanking of the housing market and subsequent financial crisis.  Then, in 2009, Citadel once again picked up most of the tab for a $1.7 billion debt exchange.

In the time since Citadel’s initial investments, the stock has lost over 75 percent of its price, but in recent months has been performing well, gaining over 32 percent since the beginning of the year. Griffin’s retreat from E-Trade, however, began back in April 2011 when Citadel sold almost half its shares in the company, at which point he began actively pushing for a sale or a merger.

Despite Thursday’s drop on the market, the company can look forward to at least two things.  Their significant efforts to reduce a $10.3 billion loan portfolio and cut costs by $100 million are no small order for a company with so much less cash than others who have had to evacuate bad assets after the housing crisis like J.P Morgan (JPM) and Bank of America (BAC).  The $10.3 billion figure is already down from $32.3 billion over 5 years ago, and the company expects to shed $450 per quarter through the rest of the year.

The other thing to which E-Trade can look forward is not having the pressure of Ken Griffin breathing down their necks.  His term on the company’s board of directors is over this spring, and he leaves the company having made $800 million on his investment.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
ETFC E*TRADE Financial Corporation 35.44 -0.06 -0.17 4,423,064
JPM JP Morgan Chase 85.12 1.05 1.25 20,844,853
VSTM Verastem Inc. 1.16 -0.02 -1.69 104,497
BAC Bank of America Corporation 22.95 0.38 1.68 182,693,888

Comments

Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets

Wealthfront

Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…

8tracks

Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.